REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $68,334,204 | -65.4% | 670,206 | -69.1% | 1.98% | -66.0% |
| Q1 2023 | $197,230,574 | +7748.4% | 2,169,276 | +2069.3% | 5.82% | +7876.7% |
| Q3 2022 | $2,513,000 | +72.5% | 100,000 | +124.8% | 0.07% | +151.7% |
| Q1 2022 | $1,457,000 | +84.2% | 44,475 | +359.6% | 0.03% | +38.1% |
| Q3 2018 | $791,000 | – | 9,677 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |